The original Medical Research Council (MRC) dyspnoea scale was developed by the British MRC in the 1950s, and it was first formally published in 1961 in a study on chronic bronchitis.1 It was designed ...
Introduction Dyspnoea is an existentially burdensome symptom in patients with advanced and progressive diseases such as cancer, chronic obstructive pulmonary disease (COPD) and advanced heart failure.
Episodic breathlessness is a common and distressing symptom in patients with advanced disease. However, breathlessness is not yet clearly defined. The aim of this project was to develop an ...
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...
The BETTER-B clinical trial found that patients with COPD and ILDs using mirtazapine for breathlessness vs placebo had slightly increased adverse events and care use. Among patients with chronic ...
In a recent study posted to the medRxiv* preprint server, a team of researchers used a multi-modal approach to examine the types, prevalence, and relevance of sleep disturbance in individuals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results